EP. 3 Recent Data on IO-Based Combination Regimens for First-line Treatment of Advanced Endometrial Carcinoma
EP. 4 Available Frontline Treatment Options for Patients With Advanced or Recurrent Endometrial Cancer
September 18th, 2026EU Approval Reccomended by CHMP for Senaparib in First-Line Advanced Ovarian CancerCHMP has recommended EU approval of senaparib for advanced ovarian cancer based on FLAMES data.Read more